-
1
-
-
73549088038
-
Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine
-
Cihlar, T.; Ray, A. S. Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine Antiviral Res. 2010, 85, 39-58
-
(2010)
Antiviral Res.
, vol.85
, pp. 39-58
-
-
Cihlar, T.1
Ray, A.S.2
-
2
-
-
23144439258
-
Intracellular interactions between nucleos(t)ide inhibitors of HIV reverse transcriptase
-
Ray, A. S. Intracellular interactions between nucleos(t)ide inhibitors of HIV reverse transcriptase AIDS Rev. 2005, 7, 113-125
-
(2005)
AIDS Rev.
, vol.7
, pp. 113-125
-
-
Ray, A.S.1
-
3
-
-
73549103358
-
The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic
-
Broder, S. The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic Antiviral Res. 2010, 85, 1-18
-
(2010)
Antiviral Res.
, vol.85
, pp. 1-18
-
-
Broder, S.1
-
4
-
-
0023056975
-
AIDS therapy. First tentative signs of therapeutic promise
-
Wright, K. AIDS therapy. First tentative signs of therapeutic promise Nature 1986, 323, 283
-
(1986)
Nature
, vol.323
, pp. 283
-
-
Wright, K.1
-
5
-
-
0025274663
-
Mitochondrial myopathy caused by long-term zidovudine therapy
-
Dalakas, M. C.; Illa, I.; Pezeshkpour, G. H.; Laukaitis, J. P.; Cohen, B.; Griffin, J. L. Mitochondrial myopathy caused by long-term zidovudine therapy N. Engl. J. Med. 1990, 322, 1098-1105
-
(1990)
N. Engl. J. Med.
, vol.322
, pp. 1098-1105
-
-
Dalakas, M.C.1
Illa, I.2
Pezeshkpour, G.H.3
Laukaitis, J.P.4
Cohen, B.5
Griffin, J.L.6
-
6
-
-
33744915313
-
3′-Azido-3′-deoxythymidine (AZT) is a competitive inhibitor of thymidine phosphorylation in isolated rat heart and liver mitochondria
-
Lynx, M. D.; Mckee, E. E. 3′-Azido-3′-deoxythymidine (AZT) is a competitive inhibitor of thymidine phosphorylation in isolated rat heart and liver mitochondria Biochem. Pharmacol. 2006, 72, 239-243
-
(2006)
Biochem. Pharmacol.
, vol.72
, pp. 239-243
-
-
Lynx, M.D.1
McKee, E.E.2
-
7
-
-
0001292364
-
Azidothymidine: Crystal structure and possible functional role of the azido group
-
Camerman, A.; Mastropaolo, D.; Camerman, N. Azidothymidine: crystal structure and possible functional role of the azido group Proc. Natl. Acad. Sci. U.S.A. 1987, 84, 8239-8242
-
(1987)
Proc. Natl. Acad. Sci. U.S.A.
, vol.84
, pp. 8239-8242
-
-
Camerman, A.1
Mastropaolo, D.2
Camerman, N.3
-
8
-
-
79957789729
-
Synthesis and anti-HIV evaluation of 3′-triazolo nucleosides
-
Roy, V.; Obikhod, A.; Zhang, H. W.; Coats, S. J.; Herman, B. D.; Sluis-Cremer, N.; Agrofoglio, L. A.; Schinazi, R. F. Synthesis and anti-HIV evaluation of 3′-triazolo nucleosides Nucleosides, Nucleotides Nucleic Acids 2011, 30, 264-270
-
(2011)
Nucleosides, Nucleotides Nucleic Acids
, vol.30
, pp. 264-270
-
-
Roy, V.1
Obikhod, A.2
Zhang, H.W.3
Coats, S.J.4
Herman, B.D.5
Sluis-Cremer, N.6
Agrofoglio, L.A.7
Schinazi, R.F.8
-
9
-
-
0035678639
-
Synthesis and anti-HIV activity of new modified 1,2,3-triazole acyclonucleosides
-
Lazrek, H. B.; Taourirte, M.; Oulih, T.; Barascut, J. L.; Imbach, J. L.; Pannecouque, C.; Witrouw, M.; De Clercq, E. Synthesis and anti-HIV activity of new modified 1,2,3-triazole acyclonucleosides Nucleosides, Nucleotides Nucleic Acids 2001, 20, 1949-1960
-
(2001)
Nucleosides, Nucleotides Nucleic Acids
, vol.20
, pp. 1949-1960
-
-
Lazrek, H.B.1
Taourirte, M.2
Oulih, T.3
Barascut, J.L.4
Imbach, J.L.5
Pannecouque, C.6
Witrouw, M.7
De Clercq, E.8
-
10
-
-
0001142573
-
Synthesis of 3′-(1,2,3-triazol-1-yl)-3′-deoxythymidines
-
Habich, D.; Barth, W.; Rosner, M. Synthesis of 3′-(1,2,3-triazol-1- yl)-3′-deoxythymidines Heterocycles 1989, 29, 2083-2088
-
(1989)
Heterocycles
, vol.29
, pp. 2083-2088
-
-
Habich, D.1
Barth, W.2
Rosner, M.3
-
11
-
-
0025037115
-
Synthesis and anti-human-immunodeficiency-virus (Hiv-1) activity of 3′-deoxy-3′-(triazol-1-yl)thymidines and 2′,3′-dideoxy- 3′-(triazol-1-yl)uridines, and inhibition of reverse-transcriptase by their 5′-triphosphates
-
Hirota, K.; Hosono, H.; Kitade, Y.; Maki, Y.; Chu, C. K.; Schinazi, R. F.; Nakane, H.; Ono, K. Synthesis and anti-human-immunodeficiency-virus (Hiv-1) activity of 3′-deoxy-3′-(triazol-1-yl)thymidines and 2′,3′-dideoxy-3′-(triazol-1-yl)uridines, and inhibition of reverse-transcriptase by their 5′-triphosphates Chem. Pharm. Bull. 1990, 38, 2597-2601
-
(1990)
Chem. Pharm. Bull.
, vol.38
, pp. 2597-2601
-
-
Hirota, K.1
Hosono, H.2
Kitade, Y.3
Maki, Y.4
Chu, C.K.5
Schinazi, R.F.6
Nakane, H.7
Ono, K.8
-
12
-
-
0025100969
-
Synthesis and antiviral activity of 3′-heterocyclic substituted 3′-deoxythymidines
-
Wigerinck, P.; Vanaerschot, A.; Janssen, G.; Claes, P.; Balzarini, J.; Declercq, E.; Herdewijn, P. Synthesis and antiviral activity of 3′-heterocyclic substituted 3′-deoxythymidines J. Med. Chem. 1990, 33, 868-873
-
(1990)
J. Med. Chem.
, vol.33
, pp. 868-873
-
-
Wigerinck, P.1
Vanaerschot, A.2
Janssen, G.3
Claes, P.4
Balzarini, J.5
Declercq, E.6
Herdewijn, P.7
-
13
-
-
28544446290
-
Synthesis and antiviral activities of 1,2,3-triazole functionalized thymidines: 1,3-dipolar cycloaddition for efficient regioselective diversity generation
-
Zhou, L.; Amer, A.; Korn, M.; Burda, R.; Balzarini, J.; De Clercq, E.; Kern, E. R.; Torrence, P. F. Synthesis and antiviral activities of 1,2,3-triazole functionalized thymidines: 1,3-dipolar cycloaddition for efficient regioselective diversity generation Antiviral Chem. Chemother. 2005, 16, 375-383
-
(2005)
Antiviral Chem. Chemother.
, vol.16
, pp. 375-383
-
-
Zhou, L.1
Amer, A.2
Korn, M.3
Burda, R.4
Balzarini, J.5
De Clercq, E.6
Kern, E.R.7
Torrence, P.F.8
-
14
-
-
77951296059
-
3′-(1,2,3-Triazol-1-yl)-3′-deoxythymidine analogs as substrates for human and Ureaplasma parvum thymidine kinase for structure-activity investigations
-
Lin, J.; Roy, V.; Wang, L.; You, L.; Agrofoglio, L. A.; Deville-Bonne, D.; McBrayer, T. R.; Coats, S. J.; Schinazi, R. F.; Eriksson, S. 3′-(1,2,3-Triazol-1-yl)-3′-deoxythymidine analogs as substrates for human and Ureaplasma parvum thymidine kinase for structure-activity investigations Bioorg. Med. Chem. 2010, 18, 3261-3269
-
(2010)
Bioorg. Med. Chem.
, vol.18
, pp. 3261-3269
-
-
Lin, J.1
Roy, V.2
Wang, L.3
You, L.4
Agrofoglio, L.A.5
Deville-Bonne, D.6
McBrayer, T.R.7
Coats, S.J.8
Schinazi, R.F.9
Eriksson, S.10
-
15
-
-
77950558113
-
3′-[4-Aryl-(1,2,3-triazol-1-yl)]-3′-deoxythymidine analogues as potent and selective inhibitors of human mitochondrial thymidine kinase
-
Van Poecke, S.; Negri, A.; Gago, F.; Van Daele, I.; Solaroli, N.; Karlsson, A.; Balzarini, J.; Van Calenbergh, S. 3′-[4-Aryl-(1,2,3-triazol- 1-yl)]-3′-deoxythymidine analogues as potent and selective inhibitors of human mitochondrial thymidine kinase J. Med. Chem. 2010, 53, 2902-2912
-
(2010)
J. Med. Chem.
, vol.53
, pp. 2902-2912
-
-
Van Poecke, S.1
Negri, A.2
Gago, F.3
Van Daele, I.4
Solaroli, N.5
Karlsson, A.6
Balzarini, J.7
Van Calenbergh, S.8
-
16
-
-
0000096835
-
Click chemistry: Diverse chemical function from a few good reactions
-
Kolb, H. C.; Finn, M. G.; Sharpless, K. B. Click chemistry: diverse chemical function from a few good reactions Angew. Chem., Int. Ed. 2001, 40, 2004-2021
-
(2001)
Angew. Chem., Int. Ed.
, vol.40
, pp. 2004-2021
-
-
Kolb, H.C.1
Finn, M.G.2
Sharpless, K.B.3
-
17
-
-
0000299952
-
Kinetics and mechanism of 1,3-dipolar cycloadditions
-
Huisgen, R. Kinetics and mechanism of 1,3-dipolar cycloadditions Angew. Chem., Int. Ed. Engl. 1963, 2, 633-645
-
(1963)
Angew. Chem., Int. Ed. Engl.
, vol.2
, pp. 633-645
-
-
Huisgen, R.1
-
18
-
-
36749014055
-
1,3-Dipolar cycloadditions. Past and future
-
Huisgen, R. 1,3-Dipolar cycloadditions. Past and future Angew. Chem., Int. Ed. Engl. 1963, 2, 565-598
-
(1963)
Angew. Chem., Int. Ed. Engl.
, vol.2
, pp. 565-598
-
-
Huisgen, R.1
-
19
-
-
0037099395
-
A stepwise Huisgen cycloaddition process: Copper(I)-catalyzed regioselective "ligation" of azides and terminal alkynes
-
Rostovtsev, V. V.; Green, L. G.; Fokin, V. V.; Sharpless, K. B. A stepwise Huisgen cycloaddition process: copper(I)-catalyzed regioselective "ligation" of azides and terminal alkynes Angew. Chem., Int. Ed. 2002, 41, 2596-2599
-
(2002)
Angew. Chem., Int. Ed.
, vol.41
, pp. 2596-2599
-
-
Rostovtsev, V.V.1
Green, L.G.2
Fokin, V.V.3
Sharpless, K.B.4
-
20
-
-
28044465418
-
Ruthenium-catalyzed cycloaddition of alkynes and organic azides
-
Zhang, L.; Chen, X.; Xue, P.; Sun, H. H.; Williams, I. D.; Sharpless, K. B.; Fokin, V. V.; Jia, G. Ruthenium-catalyzed cycloaddition of alkynes and organic azides J. Am. Chem. Soc. 2005, 127, 15998-15999
-
(2005)
J. Am. Chem. Soc.
, vol.127
, pp. 15998-15999
-
-
Zhang, L.1
Chen, X.2
Xue, P.3
Sun, H.H.4
Williams, I.D.5
Sharpless, K.B.6
Fokin, V.V.7
Jia, G.8
-
21
-
-
0348109450
-
The growing impact of click chemistry on drug discovery
-
Kolb, H. C.; Sharpless, K. B. The growing impact of click chemistry on drug discovery Drug Discovery Today 2003, 8, 1128-1137
-
(2003)
Drug Discovery Today
, vol.8
, pp. 1128-1137
-
-
Kolb, H.C.1
Sharpless, K.B.2
-
22
-
-
84878781230
-
Copper-catalyzed azide-alkyne click chemistry for bioconjugation
-
Presolski, S. I.; Hong, V. P.; Finn, M. G. Copper-catalyzed azide-alkyne click chemistry for bioconjugation Curr. Protoc. Chem. Biol. 2011, 3, 153-162
-
(2011)
Curr. Protoc. Chem. Biol.
, vol.3
, pp. 153-162
-
-
Presolski, S.I.1
Hong, V.P.2
Finn, M.G.3
-
23
-
-
67650816377
-
Growing applications of "click chemistry" for bioconjugation in contemporary biomedical research
-
Nwe, K.; Brechbiel, M. W. Growing applications of "click chemistry" for bioconjugation in contemporary biomedical research Cancer Biother. Radiopharm. 2009, 24, 289-302
-
(2009)
Cancer Biother. Radiopharm.
, vol.24
, pp. 289-302
-
-
Nwe, K.1
Brechbiel, M.W.2
-
24
-
-
33748517626
-
Azide/alkyne-"click" reactions: Applications in material science and organic synthesis
-
Binder, W. H.; Kluger, C. Azide/alkyne-"click" reactions: applications in material science and organic synthesis Curr. Org. Chem. 2006, 10, 1791-1815
-
(2006)
Curr. Org. Chem.
, vol.10
, pp. 1791-1815
-
-
Binder, W.H.1
Kluger, C.2
-
25
-
-
84863116474
-
Rapid access to chroman-3-ones through gold-catalyzed oxidation of propargyl aryl ethers
-
Wang, Y. Z.; Ji, K. G.; Lan, S.; Zhang, L. M. Rapid access to chroman-3-ones through gold-catalyzed oxidation of propargyl aryl ethers Angew. Chem., Int. Ed. 2012, 51, 1915-1918
-
(2012)
Angew. Chem., Int. Ed.
, vol.51
, pp. 1915-1918
-
-
Wang, Y.Z.1
Ji, K.G.2
Lan, S.3
Zhang, L.M.4
-
26
-
-
1542504084
-
An improved one-pot procedure for the synthesis of alkynes from aldehydes
-
Müller, S.; Liepold, B.; Bestmann, H. J. An improved one-pot procedure for the synthesis of alkynes from aldehydes Synlett 1996, 6, 521-522
-
(1996)
Synlett
, vol.6
, pp. 521-522
-
-
Müller, S.1
Liepold, B.2
Bestmann, H.J.3
-
27
-
-
0024589767
-
Rapid and efficient synthesis of nucleoside 5′- O -(1-thiotriphosphates), 5′-triphosphates and 2′,3′- cyclophosphorothioates using 2-chloro-4 H -1,3,2-benzodioxaphosphorin-4-one
-
Ludwig, J.; Eckstein, F. Rapid and efficient synthesis of nucleoside 5′- O -(1-thiotriphosphates), 5′-triphosphates and 2′,3′-cyclophosphorothioates using 2-chloro-4 H -1,3,2- benzodioxaphosphorin-4-one J. Org. Chem. 1989, 54, 631-635
-
(1989)
J. Org. Chem.
, vol.54
, pp. 631-635
-
-
Ludwig, J.1
Eckstein, F.2
-
28
-
-
0023709365
-
A highly reliable, sensitive, flow cytometric/fluorometric assay for the evaluation of the anti-HIV activity of antiviral compounds in MT-4 cells
-
Schols, D.; Pauwels, R.; Vanlangendonck, F.; Balzarini, J.; De Clercq, E. A highly reliable, sensitive, flow cytometric/fluorometric assay for the evaluation of the anti-HIV activity of antiviral compounds in MT-4 cells J. Immunol. Methods 1988, 114, 27-32
-
(1988)
J. Immunol. Methods
, vol.114
, pp. 27-32
-
-
Schols, D.1
Pauwels, R.2
Vanlangendonck, F.3
Balzarini, J.4
De Clercq, E.5
-
29
-
-
0023687234
-
Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds
-
Pauwels, R.; Balzarini, J.; Baba, M.; Snoeck, R.; Schols, D.; Herdewijn, P.; Desmyter, J.; De Clercq, E. Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds J. Virol. Methods 1988, 20, 309-321
-
(1988)
J. Virol. Methods
, vol.20
, pp. 309-321
-
-
Pauwels, R.1
Balzarini, J.2
Baba, M.3
Snoeck, R.4
Schols, D.5
Herdewijn, P.6
Desmyter, J.7
De Clercq, E.8
-
30
-
-
0021061819
-
Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
-
Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J. Immunol. Methods 1983, 65, 55-63
-
(1983)
J. Immunol. Methods
, vol.65
, pp. 55-63
-
-
Mosmann, T.1
-
31
-
-
18144387934
-
Nonnucleoside reverse transcriptase inhibitor phenotypic hypersusceptibility can be demonstrated in different assays
-
Shulman, N. S.; Delgado, J.; Bosch, R. J.; Winters, M. A.; Johnston, E.; Shafer, R. W.; Katzenstein, D. A.; Merigan, T. C. Nonnucleoside reverse transcriptase inhibitor phenotypic hypersusceptibility can be demonstrated in different assays J. Acquired Immune Defic. Syndr. 2005, 39, 78-81
-
(2005)
J. Acquired Immune Defic. Syndr.
, vol.39
, pp. 78-81
-
-
Shulman, N.S.1
Delgado, J.2
Bosch, R.J.3
Winters, M.A.4
Johnston, E.5
Shafer, R.W.6
Katzenstein, D.A.7
Merigan, T.C.8
-
32
-
-
0037131303
-
Hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in HIV-1: Clinical, phenotypic and genotypic correlates
-
Whitcomb, J. M.; Huang, W.; Limoli, K.; Paxinos, E.; Wrin, T.; Skowron, G.; Deeks, S. G.; Bates, M.; Hellmann, N. S.; Petropoulos, C. J. Hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in HIV-1: clinical, phenotypic and genotypic correlates AIDS 2002, 16, F41-F47
-
(2002)
AIDS
, vol.16
-
-
Whitcomb, J.M.1
Huang, W.2
Limoli, K.3
Paxinos, E.4
Wrin, T.5
Skowron, G.6
Deeks, S.G.7
Bates, M.8
Hellmann, N.S.9
Petropoulos, C.J.10
-
33
-
-
84879236151
-
Hypersusceptibility mechanism of tenofovir-resistant HIV to EFdA
-
Michailidis, E.; Ryan, E. M.; Hachiya, A.; Kirby, K. A.; Marchand, B.; Leslie, M. D.; Huber, A. D.; Ong, Y. T.; Jackson, J. C.; Singh, K.; Kodama, E. N.; Mitsuya, H.; Parniak, M. A.; Sarafianos, S. G. Hypersusceptibility mechanism of tenofovir-resistant HIV to EFdA Retrovirology 2013, 10, 65
-
(2013)
Retrovirology
, vol.10
, pp. 65
-
-
Michailidis, E.1
Ryan, E.M.2
Hachiya, A.3
Kirby, K.A.4
Marchand, B.5
Leslie, M.D.6
Huber, A.D.7
Ong, Y.T.8
Jackson, J.C.9
Singh, K.10
Kodama, E.N.11
Mitsuya, H.12
Parniak, M.A.13
Sarafianos, S.G.14
-
34
-
-
77950173484
-
International cohort analysis of the antiviral activities of zidovudine and tenofovir in the presence of the K65R mutation in reverse transcriptase
-
Grant, P. M.; Taylor, J.; Nevins, A. B.; Calvez, V.; Marcelin, A. G.; Wirden, M.; Zolopa, A. R. International cohort analysis of the antiviral activities of zidovudine and tenofovir in the presence of the K65R mutation in reverse transcriptase Antimicrob. Agents Chemother. 2010, 54, 1520-1525
-
(2010)
Antimicrob. Agents Chemother.
, vol.54
, pp. 1520-1525
-
-
Grant, P.M.1
Taylor, J.2
Nevins, A.B.3
Calvez, V.4
Marcelin, A.G.5
Wirden, M.6
Zolopa, A.R.7
-
35
-
-
0032506055
-
Phenotypic mechanism of HIV-1 resistance to 3′-azido-3′- deoxythymidine (AZT): Increased polymerization processivity and enhanced sensitivity to pyrophosphate of the mutant viral reverse transcriptase
-
Arion, D.; Kaushik, N.; McCormick, S.; Borkow, G.; Parniak, M. A. Phenotypic mechanism of HIV-1 resistance to 3′-azido-3′- deoxythymidine (AZT): increased polymerization processivity and enhanced sensitivity to pyrophosphate of the mutant viral reverse transcriptase Biochemistry 1998, 37, 15908-15917
-
(1998)
Biochemistry
, vol.37
, pp. 15908-15917
-
-
Arion, D.1
Kaushik, N.2
McCormick, S.3
Borkow, G.4
Parniak, M.A.5
-
36
-
-
0033165851
-
A mechanism of AZT resistance: An increase in nucleotide-dependent primer unblocking by mutant HIV-1 reverse transcriptase
-
Meyer, P. R.; Matsuura, S. E.; Mian, A. M.; So, A. G.; Scott, W. A. A mechanism of AZT resistance: an increase in nucleotide-dependent primer unblocking by mutant HIV-1 reverse transcriptase Mol. Cell 1999, 4, 35-43
-
(1999)
Mol. Cell
, vol.4
, pp. 35-43
-
-
Meyer, P.R.1
Matsuura, S.E.2
Mian, A.M.3
So, A.G.4
Scott, W.A.5
-
37
-
-
0042316944
-
Site-specific footprinting reveals differences in the translocation status of HIV-1 reverse transcriptase - Implications for polymerase translocation and drug resistance
-
Marchand, B.; Gotte, M. Site-specific footprinting reveals differences in the translocation status of HIV-1 reverse transcriptase-implications for polymerase translocation and drug resistance J. Biol. Chem. 2003, 278, 35362-35372
-
(2003)
J. Biol. Chem.
, vol.278
, pp. 35362-35372
-
-
Marchand, B.1
Gotte, M.2
-
38
-
-
34547641773
-
Effects of the translocation status of human immunodeficiency virus type 1 reverse transcriptase on the efficiency of excision of tenofovir
-
Marchand, B.; White, K. L.; Ly, J. K.; Margot, N. A.; Wang, R.; McDermott, M.; Miller, M. D.; Gotte, M. Effects of the translocation status of human immunodeficiency virus type 1 reverse transcriptase on the efficiency of excision of tenofovir Antimicrob. Agents Chemother. 2007, 51, 2911-2919
-
(2007)
Antimicrob. Agents Chemother.
, vol.51
, pp. 2911-2919
-
-
Marchand, B.1
White, K.L.2
Ly, J.K.3
Margot, N.A.4
Wang, R.5
McDermott, M.6
Miller, M.D.7
Gotte, M.8
-
39
-
-
18744365757
-
Structures of HIV-1 reverse transcriptase with pre- and post-translocation AZTMP-terminated DNA
-
Sarafianos, S. G.; Clark, A. D.; Das, K.; Tuske, S.; Birktoft, J. J.; Ilankumaran, P.; Ramesha, A. R.; Sayer, J. M.; Jerina, D. M.; Boyer, P. L.; Hughes, S. H.; Arnold, E. Structures of HIV-1 reverse transcriptase with pre- and post-translocation AZTMP-terminated DNA EMBO J. 2002, 21, 6614-6624
-
(2002)
EMBO J.
, vol.21
, pp. 6614-6624
-
-
Sarafianos, S.G.1
Clark, A.D.2
Das, K.3
Tuske, S.4
Birktoft, J.J.5
Ilankumaran, P.6
Ramesha, A.R.7
Sayer, J.M.8
Jerina, D.M.9
Boyer, P.L.10
Hughes, S.H.11
Arnold, E.12
-
40
-
-
58149133507
-
Structure and function of HIV-1 reverse transcriptase: Molecular mechanisms of polymerization and inhibition
-
Sarafianos, S. G.; Marchand, B.; Das, K.; Himmel, D. M.; Parniak, M. A.; Hughes, S. H.; Arnold, E. Structure and function of HIV-1 reverse transcriptase: molecular mechanisms of polymerization and inhibition J. Mol. Biol. 2009, 385, 693-713
-
(2009)
J. Mol. Biol.
, vol.385
, pp. 693-713
-
-
Sarafianos, S.G.1
Marchand, B.2
Das, K.3
Himmel, D.M.4
Parniak, M.A.5
Hughes, S.H.6
Arnold, E.7
-
41
-
-
77957797787
-
Structural basis of HIV-1 resistance to AZT by excision
-
Tu, X.; Das, K.; Han, Q.; Bauman, J. D.; Clark, A. D., Jr.; Hou, X.; Frenkel, Y. V.; Gaffney, B. L.; Jones, R. A.; Boyer, P. L.; Hughes, S. H.; Sarafianos, S. G.; Arnold, E. Structural basis of HIV-1 resistance to AZT by excision Nat. Struct. Mol. Biol. 2010, 17, 1202-1209
-
(2010)
Nat. Struct. Mol. Biol.
, vol.17
, pp. 1202-1209
-
-
Tu, X.1
Das, K.2
Han, Q.3
Bauman, J.D.4
Clark Jr., A.D.5
Hou, X.6
Frenkel, Y.V.7
Gaffney, B.L.8
Jones, R.A.9
Boyer, P.L.10
Hughes, S.H.11
Sarafianos, S.G.12
Arnold, E.13
-
42
-
-
0030087537
-
Single-step purification of recombinant wild-type and mutant HIV-1 reverse transcriptase
-
Fletcher, R. S.; Holleschak, G.; Nagy, E.; Arion, D.; Borkow, G.; Gu, Z. X.; Wainberg, M. A.; Parniak, M. A. Single-step purification of recombinant wild-type and mutant HIV-1 reverse transcriptase Protein Expression Purif. 1996, 7, 27-32
-
(1996)
Protein Expression Purif.
, vol.7
, pp. 27-32
-
-
Fletcher, R.S.1
Holleschak, G.2
Nagy, E.3
Arion, D.4
Borkow, G.5
Gu, Z.X.6
Wainberg, M.A.7
Parniak, M.A.8
-
43
-
-
14744267571
-
In vitro activity of structurally diverse nucleoside analogs against human immunodeficiency virus type 1 with the K65R mutation in reverse transcriptase
-
Parikh, U. M.; Koontz, D. L.; Chu, C. K.; Schinazi, R. F.; Mellors, J. W. In vitro activity of structurally diverse nucleoside analogs against human immunodeficiency virus type 1 with the K65R mutation in reverse transcriptase Antimicrob. Agents Chemother. 2005, 49, 1139-1144
-
(2005)
Antimicrob. Agents Chemother.
, vol.49
, pp. 1139-1144
-
-
Parikh, U.M.1
Koontz, D.L.2
Chu, C.K.3
Schinazi, R.F.4
Mellors, J.W.5
-
44
-
-
24644493205
-
Virion instability of human immunodeficiency virus type 1 reverse transcriptase (RT) mutated in the protease cleavage site between RT p51 and the RT RNase H domain
-
Abram, M. E.; Parniak, M. A. Virion instability of human immunodeficiency virus type 1 reverse transcriptase (RT) mutated in the protease cleavage site between RT p51 and the RT RNase H domain J. Virol. 2005, 79, 11952-11961
-
(2005)
J. Virol.
, vol.79
, pp. 11952-11961
-
-
Abram, M.E.1
Parniak, M.A.2
-
45
-
-
0037059743
-
Mutational analysis of Tyr-501 of HIV-1 reverse transcriptase - Effects on ribonuclease H activity and inhibition of this activity by N -acylhydrazones
-
Arion, D.; Sluis-Cremer, N.; Min, K. L.; Abram, M. E.; Fletcher, R. S.; Parniak, M. A. Mutational analysis of Tyr-501 of HIV-1 reverse transcriptase-effects on ribonuclease H activity and inhibition of this activity by N -acylhydrazones J. Biol. Chem. 2002, 277, 1370-1374
-
(2002)
J. Biol. Chem.
, vol.277
, pp. 1370-1374
-
-
Arion, D.1
Sluis-Cremer, N.2
Min, K.L.3
Abram, M.E.4
Fletcher, R.S.5
Parniak, M.A.6
-
46
-
-
84870702372
-
-
version 2.3; Schrödinger, LLC: New York, NY, Impact, version 5; Schrödinger, LLC: New York, NY, 2012; Prime, version 3.1; Schrödinger, LLC: New York, NY, 2012.
-
Schrödinger Suite 2012 Protein Preparation Wizard: Epik, version 2.3; Schrödinger, LLC: New York, NY, 2012; Impact, version 5; Schrödinger, LLC: New York, NY, 2012; Prime, version 3.1; Schrödinger, LLC: New York, NY, 2012.
-
(2012)
Schrödinger Suite 2012 Protein Preparation Wizard: Epik
-
-
-
47
-
-
84887929469
-
-
version 5.8; Schrödinger, LLC: New York, NY.
-
Glide, version 5.8; Schrödinger, LLC: New York, NY, 2012.
-
(2012)
Glide
-
-
-
48
-
-
84887953017
-
-
version 2.5; Schrödinger, LLC: New York, NY.
-
LigPrep, version 2.5; Schrödinger, LLC: New York, NY, 2012.
-
(2012)
LigPrep
-
-
-
49
-
-
84875208117
-
-
version 9.9; Schrödinger, LLC: New York, NY.
-
MacroModel, version 9.9; Schrödinger, LLC: New York, NY, 2012.
-
(2012)
MacroModel
-
-
-
50
-
-
84887942331
-
-
version 7.9; Schrödinger, LLC: New York, NY.
-
Jaguar, version 7.9; Schrödinger, LLC: New York, NY, 2012.
-
(2012)
Jaguar
-
-
-
51
-
-
84887878615
-
-
version 9.3; Schrödinger, LLC: New York, NY.
-
Maestro, version 9.3; Schrödinger, LLC: New York, NY, 2012.
-
(2012)
Maestro
-
-
|